Emerging treatments are significantly changing the paradigm regarding metabolic disease . MOTS-c, including various compounds , present intriguing possibilities in managing issues like type 2 glucose intolerance and excessive weight . While studies are still in progress , initial findings indicate substantial improvements in glucose control and bod